Brief: Nanovibronix Announces Encouraging Interim Results In Real World Patient Study Of Uroshield
Dec 7 (Reuters) - Nanovibronix Inc NAOV.O :
* NANOVIBRONIX ANNOUNCES ENCOURAGING INTERIM RESULTS IN REAL
WORLD
PATIENT STUDY OF UROSHIELD
* NANOVIBRONIX INC- FULL RESULTS OF STUDY ARE EXPECTED TO BE
PUBLISHED IN Q2 OF 2022
* NANOVIBRONIX - URINE ANALYSIS IS DEMONSTRATING APPROXIMATE
1 LOG
REDUCTION IN BACTERIAL NUMBERS IN MOST PATIENTS, A STATISTICALLY
SIGNIFICANT OUTCOME
Source text for Eikon: ID:nGNX3YyRvS
Further company coverage: NAOV.O
((Reuters.Briefs@thomsonreuters.com;))